|
|
|
|
| LEADER |
01000cam a2200265 4500 |
| 001 |
1669483118 |
| 003 |
DE-627 |
| 005 |
20230905070934.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
190719s2019 xxc|||||o 00| ||eng c |
| 020 |
|
|
|a 9780889755598
|9 978-0-88975-559-8
|
| 035 |
|
|
|a (DE-627)1669483118
|
| 035 |
|
|
|a (DE-599)KXP1669483118
|
| 035 |
|
|
|a (OCoLC)1158582979
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rda
|
| 041 |
|
|
|a eng
|
| 044 |
|
|
|c XD-CA
|
| 100 |
1 |
|
|a Acri, Kristina M. L.
|e verfasserin
|0 (DE-588)1191806111
|0 (DE-627)1670293831
|4 aut
|
| 245 |
1 |
0 |
|a Universal insurance for pharmaceuticals in Switzerland and the Netherlands
|c Kristina M. L. Acri née Lybecker and Bacchus Barua
|
| 264 |
|
1 |
|a Vancouver, British Columbia, Canada
|b Fraser Institute
|c 2019
|
| 300 |
|
|
|a 1 Online-Ressource (circa 62 Seiten)
|b Illustrationen
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a Computermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a Online-Ressource
|b cr
|2 rdacarrier
|
| 650 |
|
7 |
|8 1.1\x
|a Versicherungsschutz
|0 (DE-627)091398274
|0 (DE-2867)21072-0
|2 stw
|
| 650 |
|
7 |
|8 1.2\x
|a Arzneimittel
|0 (DE-627)091383145
|0 (DE-2867)14728-1
|2 stw
|
| 650 |
|
7 |
|8 1.3\x
|a Gesetzliche Krankenversicherung
|0 (DE-627)091363284
|0 (DE-2867)13415-6
|2 stw
|
| 650 |
|
7 |
|8 1.4\x
|a Niederlande
|0 (DE-627)091380170
|0 (DE-2867)17433-5
|2 stw
|
| 650 |
|
7 |
|8 1.5\x
|a Schweiz
|0 (DE-627)091388805
|0 (DE-2867)16972-1
|2 stw
|
| 700 |
1 |
|
|a Barua, Bacchus
|e verfasserin
|4 aut
|
| 856 |
4 |
0 |
|u https://www.fraserinstitute.org/studies/universal-insurance-for-pharmaceuticals-in-switzerland-and-the-netherlands
|x Verlag
|z kostenfrei
|3 Volltext
|
| 856 |
4 |
0 |
|u https://www.fraserinstitute.org/sites/default/files/universal-insurance-for-pharmaceuticals-in-switzerland-and-the-netherlands.pdf
|x Verlag
|z kostenfrei
|3 Volltext
|
| 912 |
|
|
|a GBV_ILN_20
|
| 912 |
|
|
|a ISIL_DE-84
|
| 912 |
|
|
|a SYSFLAG_1
|
| 912 |
|
|
|a GBV_KXP
|
| 912 |
|
|
|a SSG-OLC-PHA
|
| 912 |
|
|
|a SSG-OPC-PHA
|
| 912 |
|
|
|a SSG-OPC-DE-84
|
| 912 |
|
|
|a GBV_ILN_26
|
| 912 |
|
|
|a ISIL_DE-206
|
| 912 |
|
|
|a GBV_ILN_2403
|
| 912 |
|
|
|a ISIL_DE-LFER
|
| 951 |
|
|
|a BO
|
| 980 |
|
|
|2 20
|1 01
|x 0084
|b 3582880559
|y x
|z 28-01-20
|
| 980 |
|
|
|2 26
|1 01
|x 0206
|b 3495088717
|y z1k
|z 19-07-19
|
| 980 |
|
|
|2 2403
|1 01
|x DE-LFER
|b 3506615769
|c 00
|f --%%--
|d --%%--
|e n
|j --%%--
|y l01
|z 12-08-19
|
| 981 |
|
|
|2 2403
|1 01
|x DE-LFER
|r https://www.fraserinstitute.org/sites/default/files/universal-insurance-for-pharmaceuticals-in-switzerland-and-the-netherlands.pdf
|
